TY - JOUR
T1 - Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials
AU - Daniele, Gennaro
AU - Arenare, Laura
AU - Scambia, Giovanni
AU - Pisano, Carmela
AU - Sorio, Roberto
AU - Breda, Enrico
AU - De Placido, Sabino
AU - Savarese, Antonella
AU - Ferrandina, Maria Gabriella
AU - Raspagliesi, Francesco
AU - Panici, Pierluigi Benedetti
AU - Ferro, Antonella
AU - Rimanti, Anita
AU - Cormio, Gennaro
AU - Lorusso, Domenica
AU - Cecere, Sabrina Chiara
AU - Scalone, Simona
AU - Marsico, Valentina Angela
AU - Cardalesi, Cinzia
AU - Cognetti, Francesco
AU - Salutari, Vanda
AU - Attademo, Laura
AU - Guizzaro, Lorenzo
AU - Schettino, Clorinda
AU - Piccirillo, Maria Carmela
AU - Perrone, Francesco
AU - Gallo, Ciro
AU - Pignata, Sandro
PY - 2019
Y1 - 2019
N2 - Background: Chemotherapy-induced neutropenia (CIN) has been associated with improved prognosis in several cancer conditions. Contrasting data have been produced in ovarian cancer.
AB - Background: Chemotherapy-induced neutropenia (CIN) has been associated with improved prognosis in several cancer conditions. Contrasting data have been produced in ovarian cancer.
KW - Chemotherapy-induced neutropenia
KW - Cytotoxic dosing methods
KW - Meta-analysis
KW - Obstetrics and Gynecology
KW - Oncology
KW - Ovarian cancer
KW - Prognostic factors
KW - Retrospective-prospective design
KW - Chemotherapy-induced neutropenia
KW - Cytotoxic dosing methods
KW - Meta-analysis
KW - Obstetrics and Gynecology
KW - Oncology
KW - Ovarian cancer
KW - Prognostic factors
KW - Retrospective-prospective design
UR - http://hdl.handle.net/10807/135449
UR - http://www.elsevier.com/inca/publications/store/6/2/2/8/4/0/index.htt
U2 - 10.1016/j.ygyno.2019.04.012
DO - 10.1016/j.ygyno.2019.04.012
M3 - Article
SN - 0090-8258
VL - 154
SP - 83
EP - 88
JO - Gynecologic Oncology
JF - Gynecologic Oncology
ER -
